目的 探討卡前列甲酯栓聯(lián)合酚妥拉明治療產(chǎn)后尿潴留的臨床療效。方法 選取2014年7月-2015年7月武安市第一人民醫(yī)院收治的產(chǎn)后尿潴留患者92例，按治療方案的差別分為對(duì)照組和治療組，每組各46例。對(duì)照組肌肉注射甲磺酸酚妥拉明注射液10 mg；治療組在對(duì)照組基礎(chǔ)上舌下含服卡前列甲酯栓1 mg，藥物融化后緩慢吞咽，若60 min后仍排不出尿液者，重復(fù)上述治療1次。觀察兩組的臨床療效，比較兩組患者的尿潴留消失時(shí)間及住院時(shí)間。結(jié)果 治療后，對(duì)照組和治療組的總有效率分別為82.61%、95.65%，兩組比較差異有統(tǒng)計(jì)學(xué)意義（P<0.05）。治療后，治療組患者的尿潴留消失時(shí)間及住院時(shí)間明顯短于對(duì)照組，兩組比較差異具有統(tǒng)計(jì)學(xué)意義（P<0.05）。結(jié)論 卡前列甲酯栓聯(lián)合酚妥拉明治療產(chǎn)后尿潴留具有較好的臨床療效，能縮短尿潴留消失時(shí)間以及住院時(shí)間，具有一定的臨床推廣應(yīng)用價(jià)值。

Objective To explore the clinical effect of Carboprost Methylate Suppositories combined with phentolamine in treatment of postpartum urinary retention. Methods Patients (92 cases) with cerebral infarction in Wu'an First People's Hospital from July 2014 to July 2015 were enrolled in this study. According to the difference treatment plan, patients were divided into the control and treatment groups, and each group had 46 cases. Patients in the control group were im administered with Phentolamine Mesylate Injection, 10 mg. Patients in the treatment group were sublingual administered with Carboprost Methylate Suppositories on the basis of the control group, 1 mg, the drug was slowly swallowed after drug thawing, and the treatment was repeated for one time if urine cannot still be excreted after 60 min. After treatment, the clinical efficacies were evaluated, and the disappearance time of urinary retention and hospitalization time in two groups were compared. Results After treatment, the clinical efficacies in the control and treatment groups were 82.61% and 95.65%, respectively, and there was difference between two groups (P<0.05). The disappearance time of urinary retention and hospitalization time in the treatment group were significantly shorter than those in the control group, with significant difference between two groups (P<0.05). Conclusion Carboprost Methylate Suppositories combined with phentolamine has the clinical curative effect in treatment of postpartum urinary retention, and can shorten the disappearance time of urinary retention and hospitalization time, which has a certain clinical application value.